Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-01-21

FDA Approved: DESIPRAMINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved Actavis Pharma's supplemental application for desipramine hydrochloride (generic), authorizing changes under the approved labeling for the prod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DESIPRAMINE HYDROCHLORIDE (Desipramine hydrochloride)

Snippet

SUPPL AP for DESIPRAMINE HYDROCHLORIDE (DESIPRAMINE HYDROCHLORIDE)